The Latest

• February 02, 2021

  By Jet Encila

  Asia Investors Cautious About China's CanSinoBIO Vaccine Developments

  CanSinoBIO says it has met safety and efficacy requirements under a provisional evaluation of its final stage clinical test data for its COVID-19 vaccine.

  

  CanSinoBIO says it has met safety and efficacy requirements under a provisional evaluation of its final stage clinical test data for its COVID-19 vaccine.